Articles

I am very excited to announce our Third Annual Conquering the Cancer Care Continuum newsletter series. These publications will continue to address highly relevant topics in oncology management. The first issue focuses on current good manufacturing practice (cGMP) and includes articles written by a clinical oncology pharmacist, an oncology nurse practitioner, and a regulatory lawyer. Read More ›

As a nurse practitioner and a researcher whose focus is on supportive care in cancer, many of my patients and their caregivers look to me for answers to their questions regarding over-the-counter (OTC) supplements and prescription drugs used to treat various disorders. Oftentimes, patients seek my opinion concerning appropriate OTC and prescription drugs for treating such conditions as peripheral neuropathy. Read More ›

R is a 43-year-old man with a primary hepatocellular carcinoma. He was diagnosed 6 months ago with metastatic disease and today has been told that there are no remaining conventional treatment options available for the management of his cancer. To look at this patient is to see a young man who seems to be otherwise healthy, a man who continues to work full time, to travel, and to be an active husband and father. Read More ›

Confusion over the rules governing drug compounding has been an issue for many years. However, concerns about the safety and quality of compounded sterile products (CSPs), spurred by an outbreak of fungal meningitis infections that occurred in October 2012, have led to a fundamental change in the regulatory framework. Read More ›

Founded in 1922, Trinity Health was organized by the immigrants who settled Northwest North Dakota. Under the auspices of the newly formed Trinity Hospital Association, ground was broken to build a 30-bed hospital. Over the ensuing decades, Trinity expanded its facilities and increased the quality and scope of care. Trinity Health is now recognized as the region’s leading healthcare provider. As a nonprofit, fully integrated healthcare system, the network of more than 200 healthcare providers, hospitals, nursing homes, clinics, and other facilities serves an estimated 12,000 outpatients and 130,000 inpatients each year. Read More ›

This year, the American Society of Clinical Oncology (ASCO) celebrates the 50th anniversary of its founding. ASCO’s 2014 annual meeting acknowledged the society’s role in the advances made against cancer and presented the latest research and educational information about prevention, detection, and treatment of cancer. Read More ›

ou may have heard about this gene on the radio or in a news article lately. What’s all the fuss about? On August 7, 2014, the New England Journal of Medicine (NEJM) published an article discussing breast cancer risk in families with mutations in PALB2. Read More ›

Controversies in treatment-induced alopecia and hair adverse events were brought to the attention of the medical community in a presentation by Mario Lacouture, MD, at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology 2014 annual meeting. Read More ›

A small study indicates that many patients with breast cancer are not informed about lymphedema as a possible treatment-related side effect and do not know how to recognize its symptoms. Read More ›

This issue of The Oncology Nurse-APN/PA (TON), continues our coverage of the news from the recent Oncology Nursing Society (ONS) 39th Annual Congress and the 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO). Read More ›